Solanezumab
id:
solanezumab-296-6362011
title:
Solanezumab
text:
Solanezumab is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector for patients with Alzheimer's disease. The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody medication
original url:
https://en.wikipedia.org/wiki/Solanezumab
date created:
date modified:
2024-03-27T04:49:03Z
main entity:
{"identifier":"Q7555695","url":"https://www.wikidata.org/entity/Q7555695"}
image:
fields total:
13
integrity:
14